C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease

Alzheimer's disease (AD) is, in part, defined by the polymerization of tau into paired helical and straight filaments (PHF/SFs) which together comprise the fibrillar pathology in degenerating brain regions. Much of the tau in these filaments is modified by phosphorylation. Additionally, a subset also appears to be proteolytically truncated, resulting in the removal of its C terminus. Antibodies that recognize tau phosphorylated at S(396/404)or truncated at E(391) do not stain control brains but do stain brain sections very early in the disease process. We modeled these phosphorylation and truncation events by creating pseudo-phosphorylation and deletion mutants derived from a full-length recombinant human tau protein isoform (ht40) that contains N-terminal exons 2 and 3 and all four microtubule-binding repeats. In vitro assembly experiments demonstrate that both modifications greatly enhance the rates of tau filament formation and that truncation increases the mass of polymer formed, as well. Removal of as few as 12 or as many as 121 amino acids from the C terminus of tau greatly increases the rate and extent of tau polymerization. However, deletion of an additional 7 amino acids, (314)DLSKVTS(320), from the third microtubule-binding repeat results in the loss of tau's ability to form filaments in vitro. These results suggest that only part of the microtubule-binding domain (repeats 1, 2 and a small portion of 3) is crucial for tau polymerization. Moreover, the C terminus of tau clearly inhibits the assembly process; this inhibition can be partially reversed by site-specific phosphorylation and completely removed by truncation events at various sites from S(320) to the end of the molecule.

Activation of caspase-2 in apoptosis

Members of the CED-3/interleukin-1beta-converting enzyme (ICE) protease (caspase) family are synthesized as proforms, which are proteolytically cleaved and activated during apoptosis. We report here that caspase-2 (ICH-1/NEDD-2), a member of the ICE family, is activated during apoptosis by another ICE member, a caspase-3 (CPP32)-like protease(s). When cells are induced to undergo apoptosis, endogenous caspase-2 is first cleaved into three fragments of 32-33 kDa and 14 kDa, which are then further processed into 18- and 12-kDa active subunits. Up to 50 microM N-acetyl-Asp-Glu-Val-Asp-aldehyde (DEVD-CHO), a caspase-3-preferred peptide inhibitor, inhibits caspase-2 activation and DNA fragmentation in vivo, but does not prevent loss of mitochondrial function, while higher concentrations of DEVD-CHO (>50 microM) inhibit both. In comparison, although the activity of caspase-3 is very sensitive to the inhibition of DEVD-CHO (<50 nM), inhibition of caspase-3 activation as marked by processing of the proform requires more than 100 microM DEVD-CHO. Our results suggest that the first cleavage of caspase-2 is accomplished by a caspase-3-like activity, and other ICE-like proteases less sensitive to DEVD-CHO may be responsible for activation of caspase-3 and loss of mitochondrial function.

The effect of cigarette smoking on adrenal cortical hormones

We assessed the association between cigarette smoking and basal levels of adrenal cortical hormones in 11 postmenopausal smokers and 11 postmenopausal nonsmokers and measured the acute adrenal effects of cigarettes in the smokers. After an overnight food, alcohol and tobacco fast, participants smoked or sham-smoked every hr for 8 hr and provided serum samples for hormone assay before and after every other cigarette/sham, as well as before and after a corticotropin stimulation test. The postmenopausal smokers had substantially higher basal levels of androstenedione (4.60 +/- 0.42 vs. 2.70 +/- 0.36 nmol/l, P < .05) and dihydroepiandrosterone sulfate (2.88 +/- 0.36 vs. 1.91 +/- 0.16 mumol/l, P < .05) and higher average levels of cortisol and androstenedione from 0800 to 1300 hr (351.0 +/- 17.5 vs. 295.5 +/- 17.1, nmol/l and 3.58 +/- 0.42 vs. 2.51 +/- 0.19 nmol/l, P = .03, and P < .05, respectively). There were small acute effects of individual cigarettes on the hormones, but the response to corticotropin was similar in smokers and nonsmokers. Our results indicate that cigarette smoking causes a generalized disturbance in adrenal cortical hormone levels. There is no evidence for acute tolerance to the adrenocortical affects of the hourly smoking of medium-nicotine cigarettes, but these acute effects do not explain the higher hormone levels in smokers. There is no evidence for a partial block in the cortisol synthesis pathway to explain the increased adrenal androgen levels in smokers.

Molecular cloning by hybrid arrest of translation in Xenopus laevis oocytes. Identification of a cDNA encoding the type I iodothyronine 5'-deiodinase from rat liver

The enzyme(s) catalyzing the 5'-monodeiodination of thyroxine and 3,3',5'-triiodothyronine has not yet been purified, and antibodies of demonstrated specificity are not available. Thus, molecular cloning strategies which rely on the traditional screening techniques of using cDNA probes or monospecific antibodies are problematic. We previously reported that expression of type I 5'-deiodinase can be induced in Xenopus laevis oocytes by the injection of poly (A)+ RNA prepared from rat liver (St. Germain, D.L., and Morganelli, C.M. (1989) J. Biol. Chem. 264, 3054-3056). Using this expression system, we developed a hybrid arrest assay, and with it identified a 241-base pair cDNA which encodes part of this enzyme. The cDNA inhibits translation of 5'-deiodinase activity in oocytes by greater than 99% and 5'-deiodinase mRNA from rat liver poly(A)+ RNA in hybrid selection experiments. The cDNA hybridizes to a 1.9-kilobase RNA species on Northern analysis and demonstrates no significant homology to any previously cloned protein. The application of this hybrid arrest strategy for molecular cloning may prove useful for the isolation of cDNAs for proteins that are low in abundance, difficult to purify, or are subunits of a polymeric functional unit.